# E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)

> **NCT00832819** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Non-small-cell Lung Cancer

## Interventions

- **DRUG:** E7080
- **DRUG:** E7080
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00832819
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-10
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832819, "E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00832819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*